Illinois Lung Cancer Screening Malpractice Lawyer: Failure To Order Low-Dose CT Screening & Delayed Diagnosis Claims
- What Is Lung Cancer Screening Malpractice?
- Why A Patient’s Smoking History Matters
- Who May Be Eligible For Annual Low-Dose CT Lung Cancer Screening?
- How Doctors & Health Systems Can Miss Lung Cancer Screening Opportunities
- Why Earlier Lung Cancer Detection Matters
- Early-Stage Treatment & Lung-Preserving Surgical Options
- When A Missed Screening Opportunity May Become A Medical Malpractice Claim
- Proving Standard Of Care, Causation, & Harm
- Evidence & Medical Records That May Be Important
- What Losses May Be Considered In An Illinois Lung Cancer Screening Malpractice Claim?
- Illinois Medical Malpractice Deadlines
- How Strom Yen Injury Attorneys Can Help Victims In Illinois
- Frequently Asked Questions About Lung Cancer Screening Malpractice In Illinois
- Talk To An Illinois Lung Cancer Delayed Diagnosis Lawyer
Lung cancer screening can identify suspicious changes in the lungs before a person develops noticeable symptoms. They can also help identify lung nodules in their early stages. For individuals who meet established risk criteria, annual low-dose computed tomography scans offer an opportunity to detect cancer at an earlier point in its development.
That opportunity depends on more than the availability of screening technology. Physicians must recognize which patients may benefit, obtain an accurate smoking history, discuss appropriate screening options, and make sure recommended testing takes place. When these steps are overlooked, a potentially important opportunity for early detection may disappear.
Strom Yen Injury Attorneys represents patients and families in Illinois medical malpractice cases involving failures in cancer screening and delayed diagnoses. We help investigate whether missed screening opportunities resulted from preventable medical errors and whether those errors contributed to a patient’s injuries. Identifying lung nodules during the early stages allows for early interventional care.
What Is Lung Cancer Screening Malpractice? Lung cancer screening malpractice involves a breakdown in the medical process intended to identify cancer in people who may be at elevated risk. This can involve inadequate screening assessments, overlooked eligibility factors, missing referrals, or a failure to address findings that call for additional evaluation.
Unlike cases involving symptoms that were incorrectly attributed to another illness, screening-related claims often concern patients who had not yet experienced noticeable signs of cancer. The issue is whether a healthcare provider should have recognized an opportunity to recommend preventive imaging and failed to take appropriate steps.
Not every missed screening recommendation warrants a malpractice claim. An evaluation must consider the patient’s medical history, the screening recommendations applicable at the time, the provider’s responsibilities, and whether the omission contributed to a worse medical outcome.
Lung cancer screening malpractice involves a breakdown in the medical process intended to identify cancer in people who may be at elevated risk. This can involve inadequate screening assessments, overlooked eligibility factors, missing referrals, or a failure to address findings that call for additional evaluation.
Unlike cases involving symptoms that were incorrectly attributed to another illness, screening-related claims often concern patients who had not yet experienced noticeable signs of cancer. The issue is whether a healthcare provider should have recognized an opportunity to recommend preventive imaging and failed to take appropriate steps.
Not every missed screening recommendation warrants a malpractice claim. An evaluation must consider the patient’s medical history, the screening recommendations applicable at the time, the provider’s responsibilities, and whether the omission contributed to a worse medical outcome.
Why A Patient’s Smoking History Matters Smoking history is the primary trigger for lung cancer screening. The CDC links cigarette smoking to roughly 80% to 90% of lung cancer deaths, which is why every major guideline builds eligibility around cumulative tobacco exposure.
Exposure is measured in pack-years: packs per day multiplied by years smoked. One pack a day for 20 years equals 20 pack-years, as does two packs a day for 10 years. Additionally, pack years only help if someone records them.
A chart that says only “former smoker,” with no quantity or quit date, gives the next clinician and any electronic reminder system nothing to act on. Many screening claims start with a simple question: was the smoking history ever taken, updated, and written down? Age, years since quitting, and factors like COPD or family history also change over time, so it needs revisiting.
Smoking history is the primary trigger for lung cancer screening. The CDC links cigarette smoking to roughly 80% to 90% of lung cancer deaths, which is why every major guideline builds eligibility around cumulative tobacco exposure.
Exposure is measured in pack-years: packs per day multiplied by years smoked. One pack a day for 20 years equals 20 pack-years, as does two packs a day for 10 years. Additionally, pack years only help if someone records them.
A chart that says only “former smoker,” with no quantity or quit date, gives the next clinician and any electronic reminder system nothing to act on. Many screening claims start with a simple question: was the smoking history ever taken, updated, and written down? Age, years since quitting, and factors like COPD or family history also change over time, so it needs revisiting.
Who May Be Eligible For Annual Low-Dose CT Lung Cancer Screening? No single national standard governs eligibility for lung cancer screening. Organizations publish different criteria, and some of the main ones are listed below:
No single national standard governs eligibility for lung cancer screening. Organizations publish different criteria, and some of the main ones are listed below:
USPSTF
Adults 50 to 80 with a history of at least 20 pack-years who still smoke or stopped within the last 15 years. USPSTF recommends yearly LDCT for people without symptoms in this group. It says screening can end once someone has been smoke-free for 15 years, or if a serious health problem shortens life expectancy or means the person cannot or will not have surgery aimed at curing the cancer.
American Cancer Society
Ages 50 to 80 with at least 20 pack-years and no years-since-quitting limit, so a former smoker may qualify whether they quit last year or decades ago. ACS also calls for a shared decision-making conversation first and advises against screening people whose conditions substantially limit life expectancy.
Medicare/CMS
People 50 to 77 with a history of at least 20 pack-years who still smoke or stopped within the last 15 years, with a written order required after a counseling and shared decision-making visit.
NCCN
NCCN’s 2026 lung cancer screening guidelines identify individuals aged 50 and older with at least a 20-pack-year cigarette smoking history as being at higher risk and potential candidates for low-dose CT screening. Screening decisions also consider the patient’s overall health, risk factors, and ability to undergo appropriate treatment if cancer is detected.
A patient may qualify under one set of criteria and not another, so a malpractice review asks which guidelines comparable physicians recognized and used at the time of care.
How Doctors & Health Systems Can Miss Lung Cancer Screening Opportunities A patient’s eligibility for lung cancer screening can be overlooked at several points during routine medical care. These are some examples of potential breakdowns:
A patient’s eligibility for lung cancer screening can be overlooked at several points during routine medical care. These are some examples of potential breakdowns:
Incomplete Tobacco-Use Records
Medical histories may omit the number of years a patient smoked, their average daily cigarette consumption, or when they quit. Without these details, healthcare providers may not recognize that a patient meets screening criteria.
Overlooked Risk Factors
A patient’s age and smoking exposure may satisfy screening recommendations, but those details are not necessarily evaluated together. Other relevant information, including COPD and occupational exposures, may also go unconsidered.
No Screening Discussion During Routine Care
A patient may attend regular appointments without ever learning that LDCT screening is an option. When providers fail to address screening with patients who may qualify, an opportunity to identify cancer before symptoms develop can be missed.
Screening Orders Never Placed
Even when a physician recognizes that a patient may benefit from screening, the process can stall if imaging is not ordered or the patient is not referred to an appropriate screening program.
Failure To Communicate Or Follow Up On Abnormal Findings
A nodule mentioned in a radiology report can be lost between the radiologist, ordering doctor, and patient. Reports get filed without action, letters go unsent, and recommended follow-up imaging never happens.
Gaps Between Screening & Specialist Care
A concerning screening result may require input from a pulmonologist or another specialist. Unnecessary delays in coordinating that care can postpone the diagnostic process.
Why Earlier Lung Cancer Detection Matters How The Timing Of Lung Cancer Detection Affects Medical Options
The stage assigned to a lung cancer diagnosis provides important information about the extent of the disease. A tumor that remains confined to the lung presents different treatment possibilities than one that has reached nearby lymph nodes or distant organs.
For some patients, identifying cancer while it is localized may make surgical removal possible. Depending on the tumor and the patient’s health, physicians may consider procedures that remove a portion of the affected lung rather than the entire organ. Once the disease has progressed, treatment planning can become more complicated.
The American Cancer Society reports substantially different five-year relative survival rates for non-small cell lung cancer depending on how far the disease has spread:
- Localized (Still Within The Lung): Approximately 67%
- Regional (Spread To Nearby Lymph Nodes Or Tissue): Approximately 40%
- Distant (Spread To Other Parts Of The Body): Approximately 12%
These figures describe outcomes across patient populations, not the prognosis of any particular individual. They nevertheless illustrate why the timing of detection can be an important consideration when examining a potential screening-related malpractice claim.
The National Lung Screening Trial found annual LDCT screening was associated with a 20% relative reduction in lung cancer mortality compared with chest X-ray in high-risk participants.
Earlier detection often means more options. A small tumor found by screening may be treatable with surgery alone, while a larger or spread tumor may require extensive surgery, chemotherapy, radiation, immunotherapy, or a combination, or may no longer be curable.
How The Timing Of Lung Cancer Detection Affects Medical Options
The stage assigned to a lung cancer diagnosis provides important information about the extent of the disease. A tumor that remains confined to the lung presents different treatment possibilities than one that has reached nearby lymph nodes or distant organs.
For some patients, identifying cancer while it is localized may make surgical removal possible. Depending on the tumor and the patient’s health, physicians may consider procedures that remove a portion of the affected lung rather than the entire organ. Once the disease has progressed, treatment planning can become more complicated.
The American Cancer Society reports substantially different five-year relative survival rates for non-small cell lung cancer depending on how far the disease has spread:
- Localized (Still Within The Lung): Approximately 67%
- Regional (Spread To Nearby Lymph Nodes Or Tissue): Approximately 40%
- Distant (Spread To Other Parts Of The Body): Approximately 12%
These figures describe outcomes across patient populations, not the prognosis of any particular individual. They nevertheless illustrate why the timing of detection can be an important consideration when examining a potential screening-related malpractice claim.
The National Lung Screening Trial found annual LDCT screening was associated with a 20% relative reduction in lung cancer mortality compared with chest X-ray in high-risk participants.
Earlier detection often means more options. A small tumor found by screening may be treatable with surgery alone, while a larger or spread tumor may require extensive surgery, chemotherapy, radiation, immunotherapy, or a combination, or may no longer be curable.
Early-Stage Treatment & Lung-Preserving Surgical Options Surgery is a main treatment for early-stage lung cancer. The operation depends on tumor size, location, and type, lymph node status, and the patient’s overall health and lung function. Common options include:
Surgery is a main treatment for early-stage lung cancer. The operation depends on tumor size, location, and type, lymph node status, and the patient’s overall health and lung function. Common options include:
Lobectomy
A lobectomy takes out the whole lung lobe that contains the tumor and has long been the standard operation for early-stage non-small cell lung cancer. This is the procedure Pope Leo XIV underwent.
Segmentectomy
A segmentectomy removes only the affected segment of a lobe, leaving more healthy lung in place. This option is discussed in greater detail below.
Wedge Resection
This takes out only a small section of the lung around the tumor. It may be an option for very small tumors or for patients who cannot tolerate a larger operation.
Pneumonectomy
Pneumonectomy takes out the whole lung on one side. It is usually considered only when a tumor is too large or too centrally located for a smaller operation.
Radiation Therapy
Focused, high-dose radiation can treat some early-stage tumors in patients who cannot have surgery.
Chemotherapy, Immunotherapy, & Targeted Therapy
Drug treatments that may be added after surgery or used when the cancer has spread.
Segmentectomy & Why Preserving Healthy Lung Tissue Can Matter
Many lung cancer patients already have reduced lung function from smoking-related disease such as COPD. Keeping more healthy lung can mean better breathing capacity after surgery, which can affect recovery, stamina, and tolerance of any later treatment.
Two large clinical trials, one in Japan and one in North America and Australia, found that segmentectomy produced survival comparable to lobectomy for small tumors near the outer edge of the lung.
These results support segmentectomy for carefully selected patients, not every early-stage cancer. The legal point is narrower: a cancer found while small may preserve choices that a later diagnosis can close off.
When A Missed Screening Opportunity May Become A Medical Malpractice Claim
When Should A Missed Lung Cancer Screening Opportunity Be Investigated?
A missed opportunity for preventive screening warrants closer examination when the patient’s records suggest that important clinical information was overlooked or appropriate care was not provided. Circumstances that may justify a medical malpractice review include:
- Medical records contained a smoking history that warranted further screening consideration, but no assessment was documented.
- A physician had information indicating potential screening eligibility but did not address LDCT testing.
- The patient was never informed about an available screening option that a reasonably careful provider would have discussed.
- An imaging recommendation was recorded but no one ensured that the next step occurred.
- A subsequent diagnosis revealed that cancer may have been detectable at an earlier point, potentially changing the patient’s treatment options.
- Multiple visits to the physician and no order given for CT test.
The central question is not simply whether screening occurred. It is whether the medical decisions made during the patient’s care were consistent with what was reasonably expected of a provider in similar circumstances, and whether a different course of care would likely have affected the outcome.
Proving Standard Of Care, Causation, & Harm Establishing responsibility for a missed screening opportunity involves examining both the medical decision-making process and its consequences. Illinois medical malpractice claims generally require proof of three things, almost always through qualified medical experts:
Establishing responsibility for a missed screening opportunity involves examining both the medical decision-making process and its consequences. Illinois medical malpractice claims generally require proof of three things, almost always through qualified medical experts:
Expected Medical Care
What screening recommendations, clinical practices, and professional expectations applied to the patient’s circumstances at the time? Medical experts can help determine whether the provider should have recognized the need for additional screening or evaluation.
Departure From Those Expectations
Investigators examine the medical record for missed discussions, incomplete assessments, unaddressed screening eligibility, and other decisions that may have fallen below accepted medical practice.
Connection to the Patient's Outcome
The investigation must also establish whether the missed opportunity contributed to a meaningful difference in the patient’s medical condition. Experts may compare the actual diagnosis and treatment with the likely course of events had screening occurred when appropriate.
Illinois malpractice litigation requires an opinion from a qualified medical professional as stated in 735 ILCS 5/2-622.
Evidence & Medical Records That May Be Important Records often decide whether a lung cancer screening malpractice case can be evaluated. Helpful materials include:
- Primary care and specialist notes showing smoking history entries, problem lists, and screening discussions
- Prior chest X-rays and CT scans, radiology reports, and the images themselves
- Pathology and staging reports from the diagnosis
- Orders, referrals, patient portal messages, and phone or letter records showing what was sent and when
- Electronic health record audit trails and health-maintenance reminders
- Treatment records, bills, and employment records for damages
Records often decide whether a lung cancer screening malpractice case can be evaluated. Helpful materials include:
- Primary care and specialist notes showing smoking history entries, problem lists, and screening discussions
- Prior chest X-rays and CT scans, radiology reports, and the images themselves
- Pathology and staging reports from the diagnosis
- Orders, referrals, patient portal messages, and phone or letter records showing what was sent and when
- Electronic health record audit trails and health-maintenance reminders
- Treatment records, bills, and employment records for damages
What Losses May Be Considered In An Illinois Lung Cancer Screening Malpractice Claim? The financial and personal consequences of a missed screening opportunity depend on how the patient’s condition developed and what additional harm resulted from the delay. Depending on the circumstances, a claim may involve:
- Medical bills associated with additional procedures, medications, and extended treatment
- Future healthcare costs resulting from the progression of the disease
- Earnings lost during treatment and any reduction in future earning capacity
- Physical discomfort and limitations associated with the patient’s condition
- Emotional distress and the impact on everyday activities and quality of life
- Losses sustained by surviving family members in qualifying wrongful death cases
The financial and personal consequences of a missed screening opportunity depend on how the patient’s condition developed and what additional harm resulted from the delay. Depending on the circumstances, a claim may involve:
- Medical bills associated with additional procedures, medications, and extended treatment
- Future healthcare costs resulting from the progression of the disease
- Earnings lost during treatment and any reduction in future earning capacity
- Physical discomfort and limitations associated with the patient’s condition
- Emotional distress and the impact on everyday activities and quality of life
- Losses sustained by surviving family members in qualifying wrongful death cases
Illinois Medical Malpractice Deadlines Illinois gives patients two years from the point they knew, or reasonably should have known, that an injury may have been caused by negligence, but never more than four years after the care that allegedly caused the harm. Important deadline-related aspects for Illinois malpractice claims, like lung cancer screenings, include:
Illinois gives patients two years from the point they knew, or reasonably should have known, that an injury may have been caused by negligence, but never more than four years after the care that allegedly caused the harm. Important deadline-related aspects for Illinois malpractice claims, like lung cancer screenings, include:
Discovery Rule
The two-year clock may start later than the date of a cancer diagnosis, depending on when you reasonably could have connected the injury to possible negligence.
Four-Year Repose Limit
This outer deadline can bar a claim even when the cancer was found late. How it applies to missed opportunities over time depends on the facts.
Wrongful Death
For lung cancer screening medical malpractice cases that turn fatal, a lawyer in Illinois can help you pursue a wrongful death claim. Generally two years from the date of death, and the four-year repose period can still apply.
How Strom Yen Injury Attorneys Can Help Victims In Illinois Strom Yen represents patients and families in Illinois with medical malpractice cases, including delayed diagnosis and failure to diagnose cancer claims. We handle cases across the state, from Chicago and Chicagoland to Peoria, Tazewell County, and the rest of Central Illinois, where we have litigated delayed lung cancer diagnosis cases. When we review a potential case, we:
Obtain and organize medical records and imaging
Build a timeline of smoking history documentation, screening opportunities, and follow-up
Consult qualified medical experts on standard of care, causation, and staging
Explain the strengths and risks of the claim before you decide how to proceed
For more information, please see our Illinois medical malpractice and Chicago medical malpractice pages.
Strom Yen represents patients and families in Illinois with medical malpractice cases, including delayed diagnosis and failure to diagnose cancer claims. We handle cases across the state, from Chicago and Chicagoland to Peoria, Tazewell County, and the rest of Central Illinois, where we have litigated delayed lung cancer diagnosis cases. When we review a potential case, we:
Obtain and organize medical records and imaging
Build a timeline of smoking history documentation, screening opportunities, and follow-up
Consult qualified medical experts on standard of care, causation, and staging
Explain the strengths and risks of the claim before you decide how to proceed
For more information, please see our Illinois medical malpractice and Chicago medical malpractice pages.
Frequently Asked Questions About Lung Cancer Screening Malpractice In Illinois
Who Qualifies For A Low-Dose CT Lung Cancer Screening?
It depends on the guideline. USPSTF and the American Cancer Society both address adults aged 50 to 80 with at least 20 pack-years, but USPSTF limits former smokers to those who quit within 15 years and ACS does not. Medicare covers ages 50 to 77.
Is Failing To Order A Lung Cancer Screening CT Always Malpractice?
No. Guidelines inform the standard of care but do not decide it. A claim also requires proof that the care fell below accepted practice and that the delay caused harm.
Can I Sue If My Doctor Never Mentioned Lung Cancer Screening?
Possibly. It depends on whether you met recognized criteria, what a reasonably careful provider would have done, and whether earlier screening likely would have changed your diagnosis and treatment.
How Long Do I Have To File A Lung Cancer Malpractice Lawsuit In Illinois?
Usually two years from when you learned, or should have learned, that an injury may have been caused by negligence, with a firm four-year cutoff measured from the negligent care and limited exceptions.
What If My Lung Cancer Was Found At A Late Stage After A Missed Nodule?
A missed screening opportunity may warrant legal review if you met applicable screening criteria and the failure to recommend or arrange testing contributed to a later diagnosis. Medical records, screening history, and expert analysis can help establish whether earlier testing would likely have made a difference.
Can A Family File A Claim After A Loved One Dies Of Delayed Lung Cancer Diagnosis?
Yes, through a wrongful death claim, generally within two years of the date of death. Contact us promptly because the four-year repose limit can still apply.
Talk To An Illinois Lung Cancer Delayed Diagnosis Lawyer

If you or a family member was diagnosed with lung cancer after a missed screening opportunity, Strom Yen Injury Attorneys can review your records and explain your options. To begin with a free, no pressure consultation, please Contact Strom Yen Here.
Related Blog Posts
READ MORE FROM THE BLOG
According to the American Cancer Society, diesel exhaust is linked to many lung cancer deaths in the U.S. A recent article in the Wall Street Journal states that approximately 12...
Increased silica exposure is causing a surge in the number of coal miners contracting pneumoconiosis, commonly known as black lung disease. Today’s miners are now at a higher risk of...